A Randomized, Multicenter, Open Label, Comparative Study to Evaluate the Immunogenicity and Reactogenicity of a Fully Liquid Pentavalent DTwP-HepB-Hib Vaccine (MyFiveTM, Panacea Biotec Ltd.) with Pentavalent DTwP-HepB/Hib Vaccine (Tritanrix-HBTM Reconstituted With HiberixTM, GSK) in Healthy Infants.
Phase of Trial: Phase III
Latest Information Update: 30 Aug 2016
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary) ; Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 04 Jul 2012 Status changed from recruiting to discontinued as reported by Clinical Trials Registry - India.
- 15 Feb 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
- 21 Jan 2012 New trial record